MetLife Investment Management’s Amyris Inc. AMRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-107,657
Closed -$111K 3019
2023
Q2
$111K Hold
107,657
﹤0.01% 2614
2023
Q1
$146K Buy
107,657
+38,323
+55% +$54.7K ﹤0.01% 2388
2022
Q4
$106K Sell
69,334
-36,345
-34% -$81.2K ﹤0.01% 2568
2022
Q3
$309K Buy
105,679
+37,195
+54% +$101K ﹤0.01% 1999
2022
Q2
$127K Sell
68,484
-16,615
-20% -$48.9K ﹤0.01% 2597
2022
Q1
$371K Buy
85,099
+46,897
+123% +$210K ﹤0.01% 1964
2021
Q4
$207K Sell
38,202
-15,608
-29% -$146K ﹤0.01% 2031
2021
Q3
$739K Sell
53,810
-6,042
-10% -$86.5K 0.01% 1284
2021
Q2
$980K Buy
59,852
+20,245
+51% +$302K 0.01% 1173
2021
Q1
$756K Buy
39,607
+17,549
+80% +$255K 0.01% 1284
2020
Q4
$136K Buy
22,058
+18,806
+578% +$60.1K ﹤0.01% 2164
2020
Q3
$9.5K Sell
3,252
-30,500
-90% -$112K ﹤0.01% 2289
2020
Q2
$144K Buy
+33,752
New +$112K ﹤0.01% 2072

Other funds holding AMRS

MetLife Investment Management's AMRS Position: Q3 2023 in Review

MetLife Investment Management sold out of Amyris Inc. (AMRS) in Q3 2023, closing a stake of 107,657 shares — an estimated $111K sold.

MetLife Investment Management first reported a position in AMRS in Q2 2020 and held it in 13 quarters. The position peaked at $980K in Q2 2021. 18 funds tracked by Wall St. Rank hold AMRS as of Q3 2023.

  • MetLife Investment Management reported no remaining Amyris Inc. position as of Q3 2023 after selling out during the quarter.
  • MetLife Investment Management sold 107,657 Amyris Inc. shares in Q3 2023, an estimated $111K.
  • MetLife Investment Management first reported a position in Amyris Inc. in Q2 2020 and held it in 13 quarters.
  • MetLife Investment Management's Amyris Inc. position peaked at $980K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2023.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.